title: [Treatment of patients with disorders of the ovulatory function of central etiology with preparations affecting adrenergic mechanisms].
abstract: A treatment protocol has been proposed for patients with luteal phase inadequacy of central origin employing isodrin stimulation of beta-adrenergic receptors on days 5 to 10 of the cycle and fetanol stimulation of alpha-adrenergic receptors on days 10 to 14. This protocol is recommended for use in ovarian function normalization, both alone and in combination with hormonal therapy.
authors.forename: V Ia
authors.initials: VIa
authors.lastname: Ignatkov
authors.forename: A A
authors.initials: AA
authors.lastname: Pishulin
authors.forename: S I
authors.initials: SI
authors.lastname: Markovich
authors.forename: I S
authors.initials: IS
authors.lastname: Chushkova
authors.forename: A D
authors.initials: AD
authors.lastname: Dobracheva
authors.forename: S S
authors.initials: SS
authors.lastname: Pankov
authors.forename: N A
authors.initials: NA
authors.lastname: Balika
authors.forename: V N
authors.initials: VN
authors.lastname: Babichev
mesh_terms: D000858:Anovulation / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005039:Etilefrine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D007545:Isoproterenol / Q000008:administration & dosage / Q000627:therapeutic use*; D008183:Luteal Phase; D010053:Ovary / Q000503:physiopathology; D010656:Phenylephrine / Q000031:analogs & derivatives*; D011247:Pregnancy
chemical_list: D010656:Phenylephrine; D007545:Isoproterenol; D005039:Etilefrine